Journal details
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
SPRINGER · ISSN 1389-9155 · eISSN 1573-2606
SCIEScopusMEDLINEPubMedPMC
Overview
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is a Endocrinology & Metabolism journal published by SPRINGER (Netherlands). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 47 articles · 2025: 71 articles · 2024: 69 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
The impact factor recorded for REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is 8.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is listed in CAS Zone 2.
Which databases index REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.